Brentuximab vedotin APPROVED_TREATMENT(S) Hodgkin lymphoma , Anaplastic large-cell lymphoma
Brentuximab vedotin TARGET CD30
All the approved treatments for the target CD30 are hodgkin lymphoma, anaplastic large - cell lymphoma.